Literature DB >> 21312095

Management of recurrent malignant glioma--neurosurgical strategies.

Herwig Kostron1, Richard Bauer.   

Abstract

There is currently no standard for neurosurgical interventions in patients with recurrent high grade gliomas. An individualized approach is recommended as well for decision-making as for planning an intervention with resection of the outmost possible amount of tumor tissue while preserving neurological function and thus quality of life. Recent technical developments of imaging and of neuronavigation and visualization of tumor tissue with in vivo fluorescence with 5-Ala have proved helpful in improving symptoms and prolonging survival times also for patients with recurrent malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21312095     DOI: 10.1007/s10354-010-0861-7

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  7 in total

1.  Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy.

Authors:  Ellen S Mandl; C M F Dirven; D R Buis; T J Postma; W P Vandertop
Journal:  Surg Neurol       Date:  2008-02-08

Review 2.  'Recurrent' glioblastoma multiforme, when should we reoperate?

Authors:  Giuseppe M V Barbagallo; Michael D Jenkinson; Andrew R Brodbelt
Journal:  Br J Neurosurg       Date:  2008-06       Impact factor: 1.596

3.  In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid.

Authors:  W Stummer; S Stocker; A Novotny; A Heimann; O Sauer; O Kempski; N Plesnila; J Wietzorrek; H J Reulen
Journal:  J Photochem Photobiol B       Date:  1998-09       Impact factor: 6.252

4.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

5.  Is reoperation for recurrence of glioblastoma justified?

Authors:  J Guyotat; F Signorelli; D Frappaz; G Madarassy; A C Ricci; P Bret
Journal:  Oncol Rep       Date:  2000 Jul-Aug       Impact factor: 3.906

6.  Experiences with reoperation on recurrent glioblastoma multiforme.

Authors:  M Pinsker; C Lumenta
Journal:  Zentralbl Neurochir       Date:  2001

7.  Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study.

Authors:  Arya Nabavi; Holger Thurm; Basilios Zountsas; Thorsten Pietsch; Heinrich Lanfermann; Uwe Pichlmeier; Maximilian Mehdorn
Journal:  Neurosurgery       Date:  2009-12       Impact factor: 4.654

  7 in total
  2 in total

1.  F10 gene hypomethylation, a putative biomarker for glioma prognosis.

Authors:  Xiaoping Liu; Hailin Tang; Zeyou Wang; Chen Huang; Zuping Zhang; Xiaoling She; Minghua Wu; Guiyuan Li
Journal:  J Neurooncol       Date:  2011-12-13       Impact factor: 4.130

2.  Photo-Induced Oxidative Stress Impairs Mitochondrial Metabolism in Neurons and Astrocytes.

Authors:  Elena Berezhnaya; Maria Neginskaya; Anatoly B Uzdensky; Andrey Y Abramov
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.